Sang-Il Lee, Jin-Gyu Jung, In Ae Chang, Eun-Heui Jin, Jang Hee Hong
{"title":"Genetic Association Between Polymorphisms in lncRNA <i>ANRIL</i> and Gastric Cancer Susceptibility.","authors":"Sang-Il Lee, Jin-Gyu Jung, In Ae Chang, Eun-Heui Jin, Jang Hee Hong","doi":"10.1177/19450265251375929","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Objective:</i></b> Genetic variations of long noncoding RNAs are potential biomarkers for gastric cancer (GC). However, reports on the association between single nucleotide polymorphisms (SNPs) in antisense noncoding RNA in the INK4 locus (<i>ANRIL</i>) and GC risk are few. This case-control study aimed to evaluate the association between SNPs in <i>ANRIL</i>, GC risk, and subgroups in a Korean population. <b><i>Methodology:</i></b> The TaqMan genotyping assay of six SNPs in <i>ANRIL</i> was performed in 419 patients with GC and 348 controls. <b><i>Results:</i></b> After adjusting for age and gender, the following significant associations were identified: rs2157719 in the dominant model (TC+CC vs. TT) with decreased GC risk in the lymph node metastasis (LNM)-negative subgroup (<i>p</i> = 0.045, adjusted odds ratio [AOR] = 0.65, 95% confidence interval [CI] = 0.43-0.99); rs1333040 in the recessive model (CC vs. TT+TC) with increased risk in the undifferentiated subgroup (<i>p</i> = 0.032, AOR = 1.92, 95% CI = 1.06-3.50); and rs4977574 in the dominant model (AG+GG vs. AA) with decreased risk in the LNM-positive, tumor stage III (A+B+C), and undifferentiated subgroups (<i>p</i> = 0.007, AOR = 0.58, 95% CI = 0.39-0.86; <i>p</i> = 0.028, AOR = 0.63, 95% CI = 0.42-0.95; and <i>p</i> = 0.049, AOR = 0.63, 95% CI = 0.40-1.00, respectively). <b><i>Conclusion:</i></b> Our findings suggest that these SNPs in <i>ANRIL</i> are associated with GC risk and influence GC development. Further studies are needed to confirm our results in different ethnic groups and larger populations.</p>","PeriodicalId":12603,"journal":{"name":"Genetic testing and molecular biomarkers","volume":" ","pages":"233-240"},"PeriodicalIF":1.0000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Genetic testing and molecular biomarkers","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1177/19450265251375929","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/3 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Genetic variations of long noncoding RNAs are potential biomarkers for gastric cancer (GC). However, reports on the association between single nucleotide polymorphisms (SNPs) in antisense noncoding RNA in the INK4 locus (ANRIL) and GC risk are few. This case-control study aimed to evaluate the association between SNPs in ANRIL, GC risk, and subgroups in a Korean population. Methodology: The TaqMan genotyping assay of six SNPs in ANRIL was performed in 419 patients with GC and 348 controls. Results: After adjusting for age and gender, the following significant associations were identified: rs2157719 in the dominant model (TC+CC vs. TT) with decreased GC risk in the lymph node metastasis (LNM)-negative subgroup (p = 0.045, adjusted odds ratio [AOR] = 0.65, 95% confidence interval [CI] = 0.43-0.99); rs1333040 in the recessive model (CC vs. TT+TC) with increased risk in the undifferentiated subgroup (p = 0.032, AOR = 1.92, 95% CI = 1.06-3.50); and rs4977574 in the dominant model (AG+GG vs. AA) with decreased risk in the LNM-positive, tumor stage III (A+B+C), and undifferentiated subgroups (p = 0.007, AOR = 0.58, 95% CI = 0.39-0.86; p = 0.028, AOR = 0.63, 95% CI = 0.42-0.95; and p = 0.049, AOR = 0.63, 95% CI = 0.40-1.00, respectively). Conclusion: Our findings suggest that these SNPs in ANRIL are associated with GC risk and influence GC development. Further studies are needed to confirm our results in different ethnic groups and larger populations.
期刊介绍:
Genetic Testing and Molecular Biomarkers is the leading peer-reviewed journal covering all aspects of human genetic testing including molecular biomarkers. The Journal provides a forum for the development of new technology; the application of testing to decision making in an increasingly varied set of clinical situations; ethical, legal, social, and economic aspects of genetic testing; and issues concerning effective genetic counseling. This is the definitive resource for researchers, clinicians, and scientists who develop, perform, and interpret genetic tests and their results.
Genetic Testing and Molecular Biomarkers coverage includes:
-Diagnosis across the life span-
Risk assessment-
Carrier detection in individuals, couples, and populations-
Novel methods and new instrumentation for genetic testing-
Results of molecular, biochemical, and cytogenetic testing-
Genetic counseling